F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
Release Date:
08/31/2017
The Food and Drug Administration on Wednesday approved the first-ever treatment that genetically alters a patient’s own cells to fight cancer, a milestone that is expected to transform treatment in the coming years.